JPMorgan resumed coverage on Allergen (NYSE: AGN) with an Overweight rating and a price target of $325.00.

For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.

Shares of Allergen closed at $244.74 yesterday.

New Coverage

UBS Cuts Allergan (AGN) PT, Ests But Remains Above ConsensusApril 7, 2016 8:41 AM Susquehanna Downgrades Allergen (AGN) to NeutralApril 7, 2016 7:30 AM Allergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone CompanyApril 6, 2016 6:47 AM Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)April 6, 2016 6:45 AM Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer TransactionApril 6, 2016 6:45 AM